Factors Associated with Vancomycin Nephrotoxicity in the Critically Ill
Open Access
- 1 September 2015
- journal article
- research article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 43 (5), 594-599
- https://doi.org/10.1177/0310057x1504300507
Abstract
Vancomycin is a glycopeptide antibiotic commonly used in the management of methicillin-resistant Staphylococcus aureus infection. The recent increase in prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin has prompted experts to advocate for higher target trough serum concentrations. This study aimed to evaluate the potential consequences of more aggressive vancomycin therapy, by examining the association between higher serum concentrations and acute kidney injury (AKI) in a population of critically ill patients. We collected data for all patients who received vancomycin over a five-year period and evaluated the prevalence of new-onset AKI using the Risk, Injury, Failure, Loss and End-stage (RIFLE) kidney disease criteria. One-hundred and fifty-nine patients provided complete data, with 8.8% manifesting new onset AKI while receiving vancomycin. The median age was 57 (44 to 68) years, while the median trough serum concentration was 16 (10 to 19) mg/l. Multivariate logistic regression analysis identified mean trough concentration (OR=1.174, P=0.024), APACHE II score (OR=1.141, P=0.012) and simultaneous aminoglycoside prescription (OR=18.896, P=0.002) as significant predictors of AKI. These data suggest higher trough vancomycin serum concentrations are associated with greater odds of AKI in the critically ill.Keywords
This publication has 29 references indexed in Scilit:
- Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention studyInternational Journal of Antimicrobial Agents, 2011
- Implications of augmented renal clearance in critically ill patientsNature Reviews Nephrology, 2011
- Back-Calculating Baseline Creatinine with MDRD Misclassifies Acute Kidney Injury in the Intensive Care UnitClinical Journal of the American Society of Nephrology, 2010
- Acute kidney injury in critically ill burn patients. Risk factors, progression and impact on mortalityBurns, 2010
- Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?American Journal Of Medicine, 2010
- Augmented Renal ClearanceClinical Pharmacokinetics, 2010
- Clinical review: RIFLE and AKIN – time for reappraisalCritical Care, 2009
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityAntimicrobial Agents and Chemotherapy, 2008
- Clinical Pharmacokinetics of VancomycinClinical Pharmacokinetics, 1986
- APACHE IICritical Care Medicine, 1985